advertisement
Liu W 24
Showing records 1 to 24 | Display all abstracts from Liu W95200 Preservation of vision after CaMKII-mediated protection of retinal ganglion cells
Guo X
Cell 2021; 184: 4299-4314.e12
95497 Long-term outcome of a Chinese cohort idiopathic retinitis, vasculitis, aneurysms, and neuroretinits (IRVAN) patients
Qi Y
International Ophthalmology 2021; 41: 3487-3496
95395 Anterior lens capsule: biomechanical properties and biomedical engineering perspectives
Huang D
Acta Ophthalmologica 2021; 99: e302-e309
95497 Long-term outcome of a Chinese cohort idiopathic retinitis, vasculitis, aneurysms, and neuroretinits (IRVAN) patients
Zhang Y
International Ophthalmology 2021; 41: 3487-3496
95395 Anterior lens capsule: biomechanical properties and biomedical engineering perspectives
Xu C
Acta Ophthalmologica 2021; 99: e302-e309
95200 Preservation of vision after CaMKII-mediated protection of retinal ganglion cells
Zhou J
Cell 2021; 184: 4299-4314.e12
95395 Anterior lens capsule: biomechanical properties and biomedical engineering perspectives
Guo R
Acta Ophthalmologica 2021; 99: e302-e309
95200 Preservation of vision after CaMKII-mediated protection of retinal ganglion cells
Starr C
Cell 2021; 184: 4299-4314.e12
95497 Long-term outcome of a Chinese cohort idiopathic retinitis, vasculitis, aneurysms, and neuroretinits (IRVAN) patients
Liu W
International Ophthalmology 2021; 41: 3487-3496
95395 Anterior lens capsule: biomechanical properties and biomedical engineering perspectives
Ji J
Acta Ophthalmologica 2021; 99: e302-e309
95497 Long-term outcome of a Chinese cohort idiopathic retinitis, vasculitis, aneurysms, and neuroretinits (IRVAN) patients
Li L
International Ophthalmology 2021; 41: 3487-3496
95200 Preservation of vision after CaMKII-mediated protection of retinal ganglion cells
Mohns EJ
Cell 2021; 184: 4299-4314.e12
95497 Long-term outcome of a Chinese cohort idiopathic retinitis, vasculitis, aneurysms, and neuroretinits (IRVAN) patients
Ye X
International Ophthalmology 2021; 41: 3487-3496
95200 Preservation of vision after CaMKII-mediated protection of retinal ganglion cells
Li Y
Cell 2021; 184: 4299-4314.e12
95395 Anterior lens capsule: biomechanical properties and biomedical engineering perspectives
Liu W
Acta Ophthalmologica 2021; 99: e302-e309
95200 Preservation of vision after CaMKII-mediated protection of retinal ganglion cells
Chen EP
Cell 2021; 184: 4299-4314.e12
95497 Long-term outcome of a Chinese cohort idiopathic retinitis, vasculitis, aneurysms, and neuroretinits (IRVAN) patients
Chang Q; Wang M
International Ophthalmology 2021; 41: 3487-3496
95200 Preservation of vision after CaMKII-mediated protection of retinal ganglion cells
Yoon Y; Kellner CP
Cell 2021; 184: 4299-4314.e12
95497 Long-term outcome of a Chinese cohort idiopathic retinitis, vasculitis, aneurysms, and neuroretinits (IRVAN) patients
Xuan Y
International Ophthalmology 2021; 41: 3487-3496
95200 Preservation of vision after CaMKII-mediated protection of retinal ganglion cells
Tanaka K
Cell 2021; 184: 4299-4314.e12
95497 Long-term outcome of a Chinese cohort idiopathic retinitis, vasculitis, aneurysms, and neuroretinits (IRVAN) patients
Guo J
International Ophthalmology 2021; 41: 3487-3496
95200 Preservation of vision after CaMKII-mediated protection of retinal ganglion cells
Wang H
Cell 2021; 184: 4299-4314.e12
95497 Long-term outcome of a Chinese cohort idiopathic retinitis, vasculitis, aneurysms, and neuroretinits (IRVAN) patients
Xu G
International Ophthalmology 2021; 41: 3487-3496
95200 Preservation of vision after CaMKII-mediated protection of retinal ganglion cells
Liu W; Pasquale LR; Demb JB; Crair MC; Chen B
Cell 2021; 184: 4299-4314.e12